AUSTIN, Texas, Sept. 22, 2017 (GLOBE NEWSWIRE) — Molecular Templates, Inc., (Nasdaq:MTEM) a clinical stage biopharmaceutical company focused on the discovery and development of Engineered Toxin Bodies (ETBs), a new class of targeted biologic therapies that possess unique mechanisms of action in oncology, today announced that Eric E. Poma, Ph.D., Chief Executive and Chief Scientific Officer, will provide a corporate overview at the Ladenburg Thalmann 2017 Healthcare Conference, and the Cantor Fitzgerald Global Healthcare Conference.
Ladenburg Thalmann Healthcare Conference
Date: Tuesday, September 26
Time: 1:30pm Eastern Time
Location: Sofitel Hotel New York, Odeon Ballroom
Webcast: http://wsw.com/webcast/ladenburg3/mtem/
Cantor Fitzgerald Healthcare Conference
Date: Wednesday, September 27
Time: 4:35pm Eastern Time
Location: InterContinental New York Barclay Hotel, Empire Ballroom 2
Webcast: http://wsw.com/webcast/cantor6/mtem/
About Molecular Templates
Molecular Templates is focused on the discovery, development and commercialization of next-generation immunotoxins called Engineered Toxin Bodies (ETBs) for the treatment of cancers and other serious diseases. For additional information, please visit Molecular Templates’ website at www.mtem.com.
Investor Contact:
Andrew McDonald, Ph.D.
andrew@lifesciadvisors.com
646-597-6987
